Sequential endocrine therapy and chemotherapy in metastatic breast cancer: Effects on survival
暂无分享,去创建一个
[1] Moustafa,et al. Combination chemotherapy in advanced breast cancer , 1984 .
[2] R. S. Rhodes,et al. Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45‐month follow‐up of a prospective, randomized clinical trial , 1980, Cancer.
[3] A. Manni,et al. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. , 1980, Endocrinology.
[4] A. Manni,et al. Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. , 1980, Cancer treatment reports.
[5] A. Manni,et al. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. , 1980, Cancer treatment reports.
[6] K. Pritchard,et al. Tamoxifen Response - a Useful Guide to Subsequent Treatment in Premenopausal Patients with Metastatic Breast-Cancer , 1980 .
[7] K. Pritchard,et al. Tamoxifen therapy in premenopausal patients with metastatic breast cancer. , 1980, Cancer treatment reports.
[8] W. McGuire,et al. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer. , 1980, European journal of cancer.
[9] A. Manni,et al. Antihormone treatment of stage IV breast cancer , 1979, Cancer.
[10] J. Bertino,et al. Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin , 1978, Cancer.
[11] A. Manni,et al. Antiestrogen-induced remissions in stage IV breast cancer. , 1976, Cancer treatment reports.
[12] V. Devita,et al. Combination chemotherapy for advanced breast cancer: response and effect on survival. , 1976, Annals of internal medicine.